Estabrook Capital Management’s BioNTech BNTX Stock Holding History

Estabrook Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.5K	Hold	500	–	–	0.01%	205
2026 Q1	$44.4K	Hold	500	–	–	0.01%	200
2025 Q4	$47.6K	Hold	500	–	–	0.01%	191
2025 Q3	$49.3K	Hold	500	–	–	0.01%	192
2025 Q2	$53.2K	Hold	500	–	–	0.01%	179
2025 Q1	$45.5K	Hold	500	–	–	0.01%	186
2024 Q4	$57K	Hold	500	–	–	0.01%	184
2024 Q3	$59.4K	Hold	500	–	–	0.01%	192
2024 Q2	$40.2K	Hold	500	–	–	0.01%	208
2024 Q1	$46.1K	Sell	500 -600	-55%	-$57.5K	0.01%	210
2023 Q4	$116K	Hold	1,100	–	–	0.02%	151
2023 Q3	$120K	Hold	1,100	–	–	0.02%	150
2023 Q2	$119K	Hold	1,100	–	–	0.02%	156
2023 Q1	$137K	Hold	1,100	–	–	0.02%	149
2022 Q4	$165K	Hold	1,100	–	–	0.03%	142
2022 Q3	$148K	Hold	1,100	–	–	0.03%	145
2022 Q2	$164K	Hold	1,100	–	–	0.03%	142
2022 Q1	$188K	Hold	1,100	–	–	0.03%	140
2021 Q4	$284K	Buy	+1,100	New	+$301K	0.04%	134

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Estabrook Capital Management's BNTX Position: Q2 2026 in Review

Estabrook Capital Management held its BioNTech (BNTX) position steady in Q2 2026 at 500 shares worth $46.5K. The position accounts for 0.01% of the portfolio, ranked #205.

Estabrook Capital Management first reported a position in BNTX in Q4 2021 and has held it in 19 quarters since. The position peaked at $284K in Q4 2021. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Estabrook Capital Management held 500 shares of BioNTech worth $46.5K as of Q2 2026.
Estabrook Capital Management left its BioNTech share count unchanged in Q2 2026.
BioNTech made up 0.01% of Estabrook Capital Management's portfolio in Q2 2026, its #205 holding.
Estabrook Capital Management first reported a position in BioNTech in Q4 2021 and has held it in 19 quarters since.
Estabrook Capital Management's BioNTech position peaked at $284K in Q4 2021.
283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Estabrook Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.